Ofev : EPAR

Cyramza, INN-ramucirumab - European Medicines Agency

Blood clots in veins were also experienced by patients who received Cyramza, particularly when administered in combination with cytotoxic (cell-killing) cancer treatment (i.e. paclitaxel). However,...

Overall survival benefit of radium-223 chloride (Alpharadin™) in the

The Common Pain of Surrealism and Death

Evaluation of the activity and safety of CS 21 barrier genital gel

Proviron CMI

dtb.bmj.com Dare we think the unthinkable?

Endoscopic management of a penetrated gastric band